Werner director granted 3,025 restricted shares
LIVINGSTONE MICHELLE DYE reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LIVINGSTONE MICHELLE DYE reported acquisition or exercise transactions in this Form 4 filing.
Werner Enterprises director Michelle Dye Livingstone received a grant of 3,025 shares of restricted common stock on May 12, 2026 under a stockholder approved equity plan. The award carries no purchase price and is compensation-related. It vests 34% on May 12, 2027 and 33% on each of May 12, 2028 and May 12, 2029, subject to continued Board service, at which point it will be fully vested. After this grant, she directly holds 14,154 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,025 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted Stock awarded May 12, 2026 under stockholder approved equity plan. This award shall vest subject to continued Board service, 34% on May 12, 2027 (1 year after the grant date) and two annual increments of 33% each beginning May 12, 2028. The award will become fully vested on May 12, 2029.
Key Figures
Key Terms
Restricted Stock financial
stockholder approved equity plan financial
vest financial
Board service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did WERN director Michelle Dye Livingstone report?
Is the WERN Form 4 transaction an open-market buy or a compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.